Champions Oncology Stock Price, News & Analysis (NASDAQ:CSBR)

$3.63 -0.25 (-6.44 %)
(As of 01/24/2018 04:51 AM ET)
Previous Close$3.88
Today's Range$3.61 - $3.83
52-Week Range$2.19 - $4.79
Volume81,200 shs
Average Volume38,601 shs
Market Capitalization$42.63 million
P/E RatioN/A
Dividend YieldN/A

About Champions Oncology (NASDAQ:CSBR)

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.

Receive CSBR News and Ratings via Email

Sign-up to receive the latest news and ratings for CSBR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current Ratio0.61%
Quick Ratio0.61%


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$15.41 million
Price / Sales2.59
Cash FlowN/A
Price / CashN/A
Book Value$0.04 per share
Price / Book90.75


Trailing EPS($0.42)
Net Income$-6,880,000.00
Net Margins-26.26%
Return on Equity-593.68%
Return on Assets-64.57%


Outstanding Shares10,990,000

Champions Oncology (NASDAQ:CSBR) Frequently Asked Questions

What is Champions Oncology's stock symbol?

Champions Oncology trades on the NASDAQ under the ticker symbol "CSBR."

How were Champions Oncology's earnings last quarter?

Champions Oncology Inc (NASDAQ:CSBR) posted its quarterly earnings data on Thursday, December, 7th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The biotechnology company earned $5.20 million during the quarter. Champions Oncology had a negative net margin of 26.26% and a negative return on equity of 593.68%. View Champions Oncology's Earnings History.

Who are some of Champions Oncology's key competitors?

Who are Champions Oncology's key executives?

Champions Oncology's management team includes the folowing people:

  • Joel Ackerman, Chairman of the Board (Age 51)
  • Ronnie Morris M.D., President, Chief Executive Officer, Director (Age 49)
  • David Miller CPA, Vice President - Finance (Age 46)
  • Philip Breitfeld, Chief Strategic and Innovation Officer, Director (Age 63)
  • David Sidransky M.D., Lead Independent Director (Age 56)
  • Daniel N. Mendelson, Independent Director (Age 52)
  • Abba David Poliakoff, Independent Director (Age 64)
  • Scott R. Tobin, Independent Director (Age 45)

How do I buy Champions Oncology stock?

Shares of Champions Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Champions Oncology's stock price today?

One share of Champions Oncology stock can currently be purchased for approximately $3.63.

How big of a company is Champions Oncology?

Champions Oncology has a market capitalization of $42.63 million and generates $15.41 million in revenue each year. The biotechnology company earns $-6,880,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis. Champions Oncology employs 79 workers across the globe.

How can I contact Champions Oncology?

Champions Oncology's mailing address is One University Plaza Suite 307, Hackensack NJ, 07601. The biotechnology company can be reached via phone at 201-808-8400 or via email at [email protected]

MarketBeat Community Rating for Champions Oncology (CSBR)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Champions Oncology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Champions Oncology (NASDAQ:CSBR) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Champions Oncology (NASDAQ:CSBR) Earnings History and Estimates Chart

Earnings by Quarter for Champions Oncology (NASDAQ:CSBR)

Champions Oncology (NASDAQ CSBR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/7/2017Q2 2018($0.01)$5.20 millionViewListenView Earnings Details
9/14/2017Q1 2018($0.06)$5.03 millionViewN/AView Earnings Details
7/27/2017Q4 2017($0.22)$3.72 millionViewN/AView Earnings Details
3/16/2017Q3 2017($0.13)$3.57 millionViewN/AView Earnings Details
11/29/2016Q2 2017($0.05)$4.46 millionViewN/AView Earnings Details
9/9/2016Q1 2017($0.26)ViewN/AView Earnings Details
7/28/2016Q4 2016($0.30)ViewN/AView Earnings Details
3/15/2016Q316($0.21)$1.80 million$2.60 millionViewListenView Earnings Details
12/14/2015Q2 2016($0.29)ViewN/AView Earnings Details
9/10/2015Q1 2016($0.33)ViewN/AView Earnings Details
7/28/2015Q4 2015($0.60)ViewN/AView Earnings Details
3/17/2015Q3 2015($0.48)ViewN/AView Earnings Details
12/12/2014Q2 2015($0.60)ViewN/AView Earnings Details
9/11/2014Q1 2015($0.60)ViewN/AView Earnings Details
7/24/2014Q4 2014($0.36)ViewN/AView Earnings Details
3/13/2014Q3 2014($0.12)ViewN/AView Earnings Details
12/12/2013Q1 14($0.03)ViewN/AView Earnings Details
9/13/2013Q1($0.02)ViewN/AView Earnings Details
7/26/2013Q4 2013($0.36)ViewN/AView Earnings Details
3/14/2013Q3 13($0.01)ViewN/AView Earnings Details
12/13/2012Q2 2013($0.48)ViewN/AView Earnings Details
9/12/2012Q1 2013($0.34)ViewN/AView Earnings Details
7/18/2012Q4 2012($0.72)ViewN/AView Earnings Details
3/14/2012Q3 2012($0.44)ViewN/AView Earnings Details
12/14/2011Q2 2012($0.60)ViewN/AView Earnings Details
9/13/2011Q1 2012($0.48)ViewN/AView Earnings Details
7/15/2011Q4 2011($0.84)ViewN/AView Earnings Details
3/7/2011Q3 2011($0.24)ViewN/AView Earnings Details
9/13/2010Q1 2011($0.20)ViewN/AView Earnings Details
7/28/2010Q4 2010($0.24)ViewN/AView Earnings Details
3/17/2010Q3 2010($0.28)ViewN/AView Earnings Details
12/15/2009Q2 2010($0.22)ViewN/AView Earnings Details
9/14/2009Q1 2010($0.37)ViewN/AView Earnings Details
3/18/2009Q3 2009($0.23)ViewN/AView Earnings Details
12/16/2008Q2 2009($0.12)ViewN/AView Earnings Details
9/16/2008Q1 2009($0.12)ViewN/AView Earnings Details
3/6/2008Q3 2008$0.24ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Champions Oncology (NASDAQ:CSBR) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Champions Oncology (NASDAQ:CSBR)

No dividend announcements for this company have been tracked by

Insider Trades

Champions Oncology (NASDAQ CSBR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 44.30%
Institutional Ownership Percentage: 38.04%
Insider Trades by Quarter for Champions Oncology (NASDAQ:CSBR)
Insider Trades by Quarter for Champions Oncology (NASDAQ:CSBR)

Champions Oncology (NASDAQ CSBR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/21/2016Ronnie MorrisPresidentBuy30,000$1.66$49,800.001,091,347View SEC Filing  
10/19/2016Ronnie MorrisPresidentBuy10,000$1.70$17,000.001,081,347View SEC Filing  
10/18/2016Joel AckermanCEOBuy2,000$1.70$3,400.001,043,266View SEC Filing  
10/14/2016Joel AckermanCEOBuy7,300$1.67$12,191.001,035,466View SEC Filing  
10/14/2016Ronnie MorrisPresidentBuy10,305$1.66$17,106.301,061,347View SEC Filing  
10/13/2016Ronnie MorrisPresidentBuy29,695$1.67$49,590.651,041,347View SEC Filing  
10/10/2016Ronnie MorrisPresidentBuy9,537$1.66$15,831.421,026,347View SEC Filing  
10/7/2016Joel AckermanCEOBuy8,202$1.63$13,369.261,027,764View SEC Filing  
9/23/2016Joel AckermanCEOBuy33$1.65$54.451,026,764View SEC Filing  
9/21/2016Joel AckermanCEOBuy5,000$1.66$8,300.001,022,731View SEC Filing  
9/20/2016Ronnie MorrisPresidentBuy3,000$1.58$4,740.001,021,810View SEC Filing  
3/11/2015Michael Maurice BrownMajor ShareholderBuy6,250,000$0.40$2,500,000.00View SEC Filing  
3/20/2014Daniel Newman MendelsonDirectorBuy100,000$1.08$108,000.00View SEC Filing  
3/19/2014Ronnie MorrisPresidentBuy100,000$1.07$107,000.00View SEC Filing  
1/28/2013Michael Maurice BrownMajor ShareholderBuy7,000,000$0.50$3,500,000.00View SEC Filing  
1/28/2013Ronnie MorrisPresidentBuy500,000$0.50$250,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Champions Oncology (NASDAQ CSBR) News Headlines


SEC Filings

Champions Oncology (NASDAQ:CSBR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Champions Oncology (NASDAQ:CSBR) Income Statement, Balance Sheet and Cash Flow Statement


Champions Oncology (NASDAQ CSBR) Stock Chart for Wednesday, January, 24, 2018

Loading chart…

This page was last updated on 1/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.